The Effect of Chelating Agents

The potential for altering the biodistnbution of radiolabelfrom gallium-and indium-labeled mouse monoclonal antibodies was investigated in mice using metal chelating agents. The chelating agents used were desfemoxamine (DFO),diethylenetnaminepentaacetic acid (DTPA),ethylenediamine-di(O-hydroxyphenylaceticacid) (EDHPA),and

[1]  M. Strand,et al.  Stability, targeting, and biodistribution of scandium-46- and gallium-67-labeled monoclonal antibody in erythroleukemic mice. , 1985, Cancer research.

[2]  P. Doherty,et al.  DTPA-coupled antibodies labeled with yttrium-90. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  S. Larson,et al.  Monoclonal antibodies in nuclear medicine. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  J. Murray,et al.  Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5. , 1985, Cancer research.

[5]  G. Kontoghiorghes.  NEW ORALLY ACTIVE IRON CHELATORS , 1985, The Lancet.

[6]  S. Larson,et al.  IMAGING OF T-CELL LYMPHOMA BY RADIOLABELLED MONOCLONAL ANTIBODY , 1984, The Lancet.

[7]  D. Snook,et al.  TUMOUR IMAGING USING AN IMPROVED METHOD OF DTPA-COUPLED MONOCLONAL ANTIBODIES RADIOLABELLED WITH METALLIC RADIONUCLIDES , 1984, The Lancet.

[8]  J. Koziol,et al.  Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. , 1983, Cancer research.

[9]  R. Coombes,et al.  LOCATION OF METASTATIC BREAST CARCINOMA BY A MONOCLONAL ANTIBODY CHELATE LABELLED WITH INDIUM-111 , 1983, The Lancet.

[10]  R. L. Childs,et al.  Radioactive labeling of antibody: a simple and efficient method. , 1983, Science.

[11]  M. Núñez,et al.  The reticulocyte plasma membrane pathway of iron uptake as determined by the mechanism of alpha, alpha'-dipyridyl inhibition. , 1983, The Journal of biological chemistry.

[12]  J. Westwood,et al.  TUMOUR LOCALISATION WITH MONOCLONAL ANTIBODY RADIOACTIVELY LABELLED WITH METAL CHELATE RATHER THAN IODINE , 1982, The Lancet.

[13]  R. Hayes,et al.  Studies of the in vivo entry of Ga-67 into normal and malignant tissue. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  P. Galle.  Mécanisme d'élimination rénale de deux éléments du groupe IIIA de la classification périodique : l'aluminium et l'indium. , 1981 .

[15]  M. Welch,et al.  The chemistry of gallium and indium as related to radiopharmaceutical production. , 1981, International journal of nuclear medicine and biology.

[16]  M. Kostrzewa,et al.  2066. Accelerated Detection of Carbapenem Resistance Mechanisms in Enterobacteriaceae by MALDI-TOF Mass Spectrometry Using the Direct-on-Target Microdroplet Growth Assay (DOT-MGA) , 2018, Open Forum Infectious Diseases.

[17]  D. Taylor,et al.  The effect of the administration of iron on gallium 67 citrate uptake in tumours. , 1980, The British journal of radiology.

[18]  M. Blaufox,et al.  Biological distribution and excretion of DTPA labeled with Tc-99m and In-111. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  C. Sciortino,et al.  The selection and evaluation of new chelating agents for the treatment of iron overload. , 1979, The Journal of pharmacology and experimental therapeutics.

[20]  C. Hershko.  A study of the chelating agent diethylenetriaminepentaacetic acid using selective radioiron probes of reticuloendothelial and parenchymal iron stores. , 1975, The Journal of laboratory and clinical medicine.